Skip to main content
Journal cover image

Impact of Complete Revascularization in the ISCHEMIA Trial.

Publication ,  Journal Article
Stone, GW; Ali, ZA; O'Brien, SM; Rhodes, G; Genereux, P; Bangalore, S; Mavromatis, K; Horst, J; Dressler, O; Poh, KK; Nath, RK; Moorthy, N ...
Published in: J Am Coll Cardiol
September 19, 2023

BACKGROUND: Anatomic complete revascularization (ACR) and functional complete revascularization (FCR) have been associated with reduced death and myocardial infarction (MI) in some prior studies. The impact of complete revascularization (CR) in patients undergoing an invasive (INV) compared with a conservative (CON) management strategy has not been reported. OBJECTIVES: Among patients with chronic coronary disease without prior coronary artery bypass grafting randomized to INV vs CON management in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, we examined the following: 1) the outcomes of ACR and FCR compared with incomplete revascularization; and 2) the potential impact of achieving CR in all INV patients compared with CON management. METHODS: ACR and FCR in the INV group were assessed at an independent core laboratory. Multivariable-adjusted outcomes of CR were examined in INV patients. Inverse probability weighted modeling was then performed to estimate the treatment effect had CR been achieved in all INV patients compared with CON management. RESULTS: ACR and FCR were achieved in 43.4% and 58.4% of 1,824 INV patients. ACR was associated with reduced 4-year rates of cardiovascular death or MI compared with incomplete revascularization. By inverse probability weighted modeling, ACR in all 2,296 INV patients compared with 2,498 CON patients was associated with a lower 4-year rate of cardiovascular death or MI (difference -3.5; 95% CI: -7.2% to 0.0%). In comparison, the event rate difference of cardiovascular death or MI for INV minus CON in the overall ISCHEMIA trial was -2.4%. Results were similar but less pronounced with FCR. CONCLUSIONS: The outcomes of an INV strategy may be improved if CR (especially ACR) is achieved. (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches [ISCHEMIA]; NCT01471522).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

September 19, 2023

Volume

82

Issue

12

Start / End Page

1175 / 1188

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Percutaneous Coronary Intervention
  • Myocardial Revascularization
  • Myocardial Infarction
  • Humans
  • Coronary Artery Disease
  • Coronary Artery Bypass
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stone, G. W., Ali, Z. A., O’Brien, S. M., Rhodes, G., Genereux, P., Bangalore, S., … ISCHEMIA Research Group. (2023). Impact of Complete Revascularization in the ISCHEMIA Trial. J Am Coll Cardiol, 82(12), 1175–1188. https://doi.org/10.1016/j.jacc.2023.06.015
Stone, Gregg W., Ziad A. Ali, Sean M. O’Brien, Grace Rhodes, Philippe Genereux, Sripal Bangalore, Kreton Mavromatis, et al. “Impact of Complete Revascularization in the ISCHEMIA Trial.J Am Coll Cardiol 82, no. 12 (September 19, 2023): 1175–88. https://doi.org/10.1016/j.jacc.2023.06.015.
Stone GW, Ali ZA, O’Brien SM, Rhodes G, Genereux P, Bangalore S, et al. Impact of Complete Revascularization in the ISCHEMIA Trial. J Am Coll Cardiol. 2023 Sep 19;82(12):1175–88.
Stone, Gregg W., et al. “Impact of Complete Revascularization in the ISCHEMIA Trial.J Am Coll Cardiol, vol. 82, no. 12, Sept. 2023, pp. 1175–88. Pubmed, doi:10.1016/j.jacc.2023.06.015.
Stone GW, Ali ZA, O’Brien SM, Rhodes G, Genereux P, Bangalore S, Mavromatis K, Horst J, Dressler O, Poh KK, Nath RK, Moorthy N, Witkowski A, Dwivedi SK, Bockeria O, Chen J, Smanio PEP, Picard MH, Chaitman BR, Berman DS, Shaw LJ, Boden WE, White HD, Fremes SE, Rosenberg Y, Reynolds HR, Spertus JA, Hochman JS, Maron DJ, ISCHEMIA Research Group. Impact of Complete Revascularization in the ISCHEMIA Trial. J Am Coll Cardiol. 2023 Sep 19;82(12):1175–1188.
Journal cover image

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

September 19, 2023

Volume

82

Issue

12

Start / End Page

1175 / 1188

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Percutaneous Coronary Intervention
  • Myocardial Revascularization
  • Myocardial Infarction
  • Humans
  • Coronary Artery Disease
  • Coronary Artery Bypass
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services